Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sateri is a global leader in the production of viscose fiber, a bio-based material derived from wood pulp. As part of the Royal Golden Eagle (RGE) group, the company operates major manufacturing facilities in China and is one of the world's largest producers of viscose staple fiber. In the healthcare and life sciences sector, Sateri provides high-quality fibers used in medical textiles, hygiene products, and non-woven applications such as surgical masks and wipes. Additionally, the company produces dissolving pulp, which serves as a critical raw material for pharmaceutical excipients like cellulose ethers used in drug formulation and delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Säteri.